CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
56.06
22-November-24 16:44:58
15 minutes delayed
Stocks
-0.97
-1.70%
Today's range
55.34 - 57.10
ISIN
N/A
Source
NASDAQ
-
03 Jun 2024 12:00:00 By Nasdaq GlobeNewswire
-
30 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
22 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 May 2024 17:38:21 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
08 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
02 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
19 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
-
11 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
28 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
12 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
10 Jan 2024 16:33:42 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
18 Dec 2023 16:05:00 By Nasdaq GlobeNewswire
-
11 Dec 2023 16:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences
20 Nov 2023 16:05:00 By Nasdaq GlobeNewswire